1-3 of 3
Raymond Urbanski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase Ⅱ,Open-Label, Multicenter, Single-Arm Study Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Chinese Patients with Polycythemia Vera Resistant or Intolerant to Hydroxyurea(HU)

Jie Jin, Lei Zhang, Zonghong Shao, Jie Bai, Suning Chen, Minghui Duan, Sujiang Zhang, Hu Zhou, Na Xu, Xin Du, Xuelan Zuo, Li Wang, Pei Li, Xuhan Zhang, Daoxiang Wu, Yaning Li, Jingjing Zhang, Wei Wang, Warren Shen, Oleh Zagrijtschuk, Raymond Urbanski, Toshiaki Sato, Albert Qin, Zhijian Xiao
Journal: Blood
Blood (2022) 140 (Supplement 1): 6858–6859.
https://doi.org/10.1182/blood-2022-165789
Published: 2022
Journal Articles

Surpass-ET Trial: A Phase 3, Open-Label, Multicenter, Randomized, Active-Controlled Study to Assess Pharmacokinetics and Compare the Efficacy, Safety, and Tolerability of P1101 Vs Anagrelide As Second Line Therapy for Essential Thrombocythemia

Ruben A. Mesa, Norio Komatsu, Harinder Gill, Jie Jin, Sung-Eun Lee, Hsin-An Hou, Toshiaki Sato, Albert Qin, Raymond Urbanski, Weichung Shih, Oleh Zagrijtschuk, Craig Zimmerman, Srdan Verstovsek
Journal: Blood
Blood (2021) 138 (Supplement 1): 1491.
https://doi.org/10.1182/blood-2021-147417
Published: 2021
Journal Articles

The Design of a Phase 2 Study to Evaluate the Safety and Efficacy of Ropeginterferon Alfa-2b (P1101) in Chinese Patients with Polycythemia Vera Resistant or Intolerant to Hydroxyurea (HU)

Jie Jin, Lei Zhang, Su-Jiang Zhang, Suning Chen, Ming-hui Duan, Jingjing Zhang, Wei Wang, Warren Shen, Oleh Zagrijtschuk, Raymond Urbanski, Albert Qin, Zhijian Xiao
Journal: Blood
Blood (2021) 138 (Supplement 1): 4628.
https://doi.org/10.1182/blood-2021-146449
Published: 2021